2024/0368,214 | POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF | Aug 25, 22 | Nov 07, 24 | Not available |
2024/0199,683 | ANDROGEN RECEPTOR MODULATORS | Mar 14, 22 | Jun 20, 24 | Not available |
2024/0199,684 | PROCESS FOR THE PREPARATION OF DROSPIRENONE AS A FINE POWDER THROUGH A DOUBLE CHANGE OF CRYSTALLINE FORM | Apr 08, 22 | Jun 20, 24 | INDUSTRIALE CHIMICA S.R.L. |
2024/0101,592 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | Nov 22, 21 | Mar 28, 24 | Not available |
2023/0295,220 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | Dec 16, 22 | Sep 21, 23 | Not available |
2023/0061,432 | NEW TECHNOLOGY TO CONJUGATE THE TACCALONOLIDE MICROTUBULE STABILIZERS WITH LINKERS/PAYLOADS | Mar 06, 20 | Mar 02, 23 | Not available |
2022/0162,258 | Method for Obtaining Gamma-Oryzanol | Jul 29, 20 | May 26, 22 | Not available |
2022/0024,969 | METHOD FOR EXTRACTING ASTRAGALOSIDE IV FROM FRESH RADIX ASTRAGALI | Jul 20, 21 | Jan 27, 22 | Not available |
2021/0323,997 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | Jun 09, 21 | Oct 21, 21 | Not available |
2021/0188,897 | NEUROACTIVE STEROIDS AND COMPOSITIONS AND METHODS THEREOF | Nov 16, 20 | Jun 24, 21 | Not available |
2021/0040,142 | C17 POLAR-SUBSTITUTED HETEROAROMATIC SYNTHETIC TRITERPENOIDS AND METHODS OF USE THEREOF | Jul 20, 20 | Feb 11, 21 | Reata Pharmaceuticals, Inc. |
2020/0048,301 | EPOXY-(METH)ACRYLATE MONOMERS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME | Aug 13, 19 | Feb 13, 20 | Not available |
2019/0359,647 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | Aug 07, 19 | Nov 28, 19 | Not available |
2019/0300,565 | Contraceptive Use of Triterpenoids | Jun 18, 19 | Oct 03, 19 | The Regents of the University of California |
2019/0031,709 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | Feb 02, 17 | Jan 31, 19 | Not available |
2018/0305,398 | C-3 NOVEL TRITERPENONE WITH C-28 UREA DERIVATIVES AS HIV INHIBITORS | Oct 12, 16 | Oct 25, 18 | Not available |
2018/0289,725 | TOMATIDINE, ANALOGS THEREOF, COMPOSITIONS COMPRISING SAME, AND USES FOR SAME | Jun 08, 18 | Oct 11, 18 | The University of Iowa Research Foundation; The United States Government as Represented by the Department of Veterans Affairs; |
2018/0237,383 | NATURAL PRODUCT ANALOGS INCLUDING AN ANTI-INFLAMMATORY CYANOENONE PHARMACORE AND METHODS OF USE | Oct 24, 17 | Aug 23, 18 | Reata Pharmaceuticals, Inc. |
2018/0118,657 | METHODS FOR INHIBITING MUSCLE ATROPHY | Nov 06, 17 | May 03, 18 | The University of Iowa Research Foundation; The United States of America as represented by the Secretary of the Department of Veterans Affairs; |
2016/0318,973 | COMPOSITIONS AND METHODS FOR INCREASING TELOMERASE ACTIVITY | Dec 10, 15 | Nov 03, 16 | TELOMERASE ACTIVATION SCIENCES, INC. |